Vienna Austria 21 - 24 June 2023

European Association for the Study of the Liver (EASL 2023)

Presentation schedule and materials

The congress symposium is no longer available

Wednesday, 21 June 2023
POSTER
A social media listening study of patients experiences toward NAFLD (LISTEN-NAFLD)
Jeffrey V. Lazarus1,2; William Alazawi3; Ron Basuroy4; Laurent Castera5; Dmitrii Estulin6; Yiannoula Koulla7; Preethy Prasad4; Manuel Romero-Gomez8; Vincent Wai-Sun Wong9, Jörn M. Schattenberg10
Slide
Poster
Video
Thursday, 22 June 2023
POSTER
Liver fibrosis is associated with cardiovascular disease burden amongst patients with non-alcoholic steatohepatitis: the unCoVer-NASH longitudinal cohort study
Kathleen E. Corey1; Anurag Mehta2; Kamal Kant Mangla3; Abhishek Shankar Chandramouli4; Ahsan Shoeb Patel3; Sharat Varma3; Elisabetta Bugianesi5
Slide
Poster
Video
POSTER
Prevalence of, and effect of semaglutide on, features of non-alcoholic steatohepatitis using SomaSignal tests in patients with obesity with/without type 2 diabetes, and correlation of SomaSignal tests with histology in patients with non-alcoholic steatohepatitis: analysis of data from three randomized trials
Jörn M. Schattenberg1; Henning Grønbæk2; Iris Kliers3; Steen Ladelund3; Michelle T. Long3; Sune Boris Nygård3; Arun J. Sanyal4; Melanie Davies5,6
Slide
Poster
Video
POSTER
Treatment monitoring with the Agile 3+ score in patients with non-alcoholic steatohepatitis: analysis of data from a randomised placebo-controlled trial of semaglutide
Laurent Castéra1; Céline Fournier-Poizat2; Julie Foucquier2; Mette Skalshøi Kjær3; Niels Krarup3; Véronique Miette2; Sune Boris Nygård3; Ahsan Shoeb Patel3; Laurent Sandrin2; Jörn M Schattenberg4
Slide
Poster
POSTER
Similar weight loss with semaglutide regardless of diabetes and cardiometabolic parameters in individuals with non-alcoholic fatty liver disease
Anne-Sophie Sejling1; Matthew J. Armstrong2; Takeshi Okanoue3; Mads Sundby Palle1; Mohamed Tawfik1; Michael Roden4
MATERIALS AVAILABLE
Slide
Poster, Infographic
Friday, 23 June 2023
ORAL PRESENTATION
Effect of semaglutide 2.4 mg on alanine aminotransferase in adolescents with obesity: a post-hoc analysis of the STEP TEENS trial
Daniel Weghuber1; Burak Demirel2; Igne Gies3; Lise Lotte Gluud4; Aske Thorn Iversen5; Signe Schmidt6; Rasmus Sørrig2; Martin Wabitsch7; Mazen Noureddin8,9
Slide
Video
Keywords
NASH